Intra-arterial chemotherapy combined with BCG immunotherapy is more effective than intra-arterial chemotherapy plus intravesical chemotherapy or standard BCG immunotherapy in preventing the recurrence and progression of high-risk non–muscle-invasive bladder cancerShuhang Luo, Bin Huang, Enyou Si et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 1
Intra-arterial chemotherapy plus BCG, a promising combination adjuvant treatment for high-risk NMIBCShuhang Luo, Bin Huang, Rui Yang et al.|Research Square|2022Cited by 0
Development and assessment of a nomogram for predicting the probability of achieving trifecta in patients with urolithiasis undergoing percutaneous nephrolithotomyShuhang Luo, Qinsong Zeng, Junxing Chen et al.|Research Square|2022Cited by 0